Tizanidine
Product Images NDC 53217-344

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 53217-344). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (Tizanidine 2mg 1)

Chemical structure diagram of Tizanidine hydrochloride, showing the molecular arrangement and identified atoms including chlorine (Cl) and labeled hydrochloride (HCl). The structure depicts multiple rings with nitrogen and sulfur atoms.*

FDA Label Image

Figure-1 (Tizanidine 2mg 2)

A pharmacokinetic line graph showing plasma concentration (ng/mL) of Tizanidine over time (hours) from dosing. It compares 4 mg Tizanidine tablets and capsules taken with and without food, depicting concentration curves for each condition from 0 to 24 hours post-dose.*

FDA Label Image

Figure 3 (Tizanidine 2mg 3)

A line graph depicting improvement in Ashworth Score over time (hours post-dose) for 16 mg tizanidine, 8 mg tizanidine, and placebo groups. The x-axis represents hours post-dose from 0 to 6, and the y-axis represents improvement score ranging approximately from -5 to 0. Data points include error bars for variability.*

FDA Label Image

Figure 4 (Tizanidine 2mg 4)

A line graph comparing the improvement in Ashworth Score for Tizanidine at a mean dose of 28.8 mg versus placebo at three time points: end of titration (study week 3), end of maintenance (study week 7), and endpoint (last observation carried forward). The y-axis shows improvement scores ranging from -6 to 2, with error bars indicating variability around each mean score.*

FDA Label Image

53217-0344_tizanidine_2mg (Tizanidine 2mg 5)

Tizanidine, USP 2mg tablet packaging label showing a bottle containing 30 tablets. The label indicates the active ingredient as tizanidine hydrochloride, USP 2.288mg equivalent to 2mg tizanidine base. It is a generic product for Zanaflex, labeled by Aidarex Pharmaceuticals LLC. The manufacturer is Unichem Laboratories Ltd, India. The label includes dosing instructions, NDC 53217-0344-30, lot number, and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.